ARPA-H Launches SPECTRA Program to Revolutionize Autism Diagnosis and Precision Care

ARPA-H announces the SPECTRA initiative, a federal effort to develop new tools for earlier and more accurate autism diagnosis, aiming to integrate precision medicine approaches. The program will fund multidisciplinary research teams across universities and biotech firms to create biomarkers and digital assessment platforms.

SPECTRA targets gaps in current diagnostic practices by supporting development of blood‑based tests, neuroimaging protocols, and AI‑driven analytics that can differentiate autism subtypes. Researchers will receive up to $200 million in grants over five years, with milestones tied to clinical validation and regulatory pathways.

Autism advocates welcome the focus on precision care, noting that earlier detection can guide personalized interventions. The initiative also pledges to share data openly with the scientific community, aiming to accelerate treatment discovery and reduce long‑term support costs for families.

HHS will oversee the program through its Office of the Assistant Secretary for Health, establishing an advisory board of clinicians, researchers, and parent representatives to monitor progress and ensure ethical use of emerging diagnostics.